NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
Jennifer M. Weiss, Mallory Campbell(National Comprehensive Cancer Network), Priyanka Kanth(University of Utah), Rachel Hodan(Stanford Health Care), Michael J. Hall(Université Paris Cité), Heather Hampel(City Of Hope National Medical Center), Arnold J. Markowitz(Memorial Sloan Kettering Cancer Center), David Shibata(St. Jude Children's Research Hospital), Susan Darlow(National Comprehensive Cancer Network), Bryson W. Katona(Washington University in St. Louis), Xavier Llor(Yale Cancer Center), Carol A. Burke(Cleveland Clinic), Benjamin Swanson(The Ohio State University Wexner Medical Center), Olumide B. Gbolahan(University of Colorado Cancer Center), Brittany M. Szymaniak(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Lee-may Chen(UCSF Helen Diller Family Comprehensive Cancer Center), Sara Pirzadeh‐Miller(Southwestern Medical Center), William M. Grady(Fred Hutch Cancer Center), Gregory Idos(City Of Hope National Medical Center), Seth Felder(Moffitt Cancer Center), Katherine M Clayback(Roswell Park Comprehensive Cancer Center), Georgia L. Wiesner(Breast Cancer Research Foundation), Samir Gupta(UC San Diego Health System), Susan Dallas, Mae Zakhour(Comprehensive Blood & Cancer Center), Laura W. Lamps(University of Arkansas for Medical Sciences), Daniel C. Chung(Massachusetts General Hospital), Lisen Axell(University of Colorado Cancer Center), Andrew M. D. Wolf(Cancer Institute (WIA)), Francis M. Giardiello, Mary A. Dwyer(National Comprehensive Cancer Network), N. Jewel Samadder(Huntsman Cancer Institute), Matthew B. Yurgelun(Dana-Farber Brigham Cancer Center)
Cited by 155
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
The Molecular Basis of Turcot's Syndrome
|New England Journal of Medicine|1995|1.1k